Cervical Cancer

More documents

Recommendations

Info

HPV 人類乳突病毒與子宮頸癌 0–1 Year 0–5 Years 1–20 Years 持續感染 HPV 感染清除 CIN1 CIN2/3 子宮頸癌子宮頸癌 YU2009
篩檢-1 首次抹片結果為難以判讀者,於6個月內再次接受抹片檢查的比率。篩檢-2a 首次抹片結果為4(ASCUS)者,於6個月內已追蹤的比率。篩檢-2b 首次抹片結果為6,7(CIN 1) 者,於6個月內已追蹤的比率。篩檢-3a1 首次抹片檢查結果為8-11(CIN2,3),16(ASC-HSIL),17(HSIL)者,於2 個月內接受陰道鏡檢查的比率。篩檢-3a2 首次抹片檢查結果為8-11(CIN2,3),16(ASC-HSIL),17(HSIL)者,於2 個月內接受切片檢查的比率。篩檢-3b1 首次抹片檢查結果為5(AGCUS),15AGC-N),18(AIS)者,於2 個月內接受陰道鏡檢查的比率。篩檢3-b2 首次抹片檢查結果為5(AGCUS),15AGC-N),18(AIS)者,於2 個月內接受切片檢查的比率。篩檢-4a 首次抹片結果為16(ASC-HSIL)者,於2個月內其組織病理檢查結果亦為03,04, 05,07-10,12的比率。篩檢-4b 首次抹片結果為8-11(CIN2,3)者,於2個月內其組織病理檢查結果亦為03,04, 05,07-10,12的比率。篩檢-5 首次抹片結果為首次8-13及5者,於6個月內於陰道鏡下實施切片的比率。
Page 1 and 2: 子宮頸癌 Cervical Cancer 三
Page 3 and 4: 87/98 台灣女性主要癌症死
Page 5 and 6: Risk Factors for HPV Infection Wome
Page 7 and 8: HPV Clearance ▪ In women 15-25 ye
Page 9 and 10: HPV Disease Progression ▪ In a st
Page 11: Normal LSIL HSIL Invasion CIN1 CIN2
Page 15 and 16: 治療-a 切片結果為04,05,07-10
Page 17 and 18: 子宮頸癌疫苗誘出體內抗
Page 20: 子宮頸侵襲癌
Page 24 and 25: Surgical Endpoints 1900-2000 Remov
Page 27 and 28: Radical Hysterectomy
Page 30 and 31: 診療-1 原發子宮頸癌病人
Page 32 and 33: Salvage Treatment after Previous Su
Page 34 and 35: Chemotherapy in advanced & recurren
Page 36 and 37: 293 patients Cervical cancer Stage
Page 38 and 39: GOG 204: Schema • Patients with s
Page 40 and 41: 腫瘤生長需要血管新生 TAF
Page 44 and 45: Cervical cancer stage IVB, recurren
Page 46 and 47: Chemotherapy for advanced, recurren
Page 48: 謝謝聆聽敬請指

Cervical Cancer

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?